| Issue Date | Title | Author(s) |
| 2022-01-01 | Biogenic metal sulfide nanoparticles synthesis and applications for biomedical and environmental technology | Ragu Nandhakumar, S; Rajeshkumar, S; Anand, RS; Malyla, V; Dua, K; Ezhilarasan, D; Lakshmi, T |
| 2021-07-03 | Targeting Molecular and Cellular Mechanisms in Tuberculosis | Singh, L; Dua, K; Kumar, S; Kumar, D; Majhi, S |
| 2021-07-31 | Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches | Chan, Y; Ng, SW; Liew, HS; Pua, LJW; Soon, L; Lim, JS; Dua, K; Chellappan, DK |
| 2021-07-03 | Future Prospects and Challenges in Targeting Cellular and Molecular Mechanisms in Respiratory Diseases | Verma, N; Thapa, K; Dua, K |
| 2022-01-01 | Advanced drug delivery systems targeting metabolic disorders: erythropoietic protoporphyria | Verma, N; Thapa, K; Kanojia, N; Dureja, H; Dua, K |
| 2022-01-01 | Advanced drug delivery system in the treatment of hyperglycemia and hypoglycemia | Arora, V; Kabra, A; Sharma, RB; Dureja, H; Dua, K |
| 2022-01-01 | Advanced drug delivery systems targeting to improve therapeutic outcomes in porphyria | Basetty, V; Deruiter, J; Pathak, S; Dua, K; Dhanasekaran, M |
| 2021-01-01 | Introduction to cancer cell biology | Shaikh, MA; Gilhotra, R; Singh, SK; Rawat, S; Gupta, G; Hussain, S; Singh, Y; Satija, S; Mehta, M; Dua, K |
| 2022-01-01 | Emerging drug delivery in the treatment of hyperpituitarism and hypopituitarism | Arora, V; Kabra, A; Puri, R; Vyas, G; Dua, K; Dureja, H |
| 2022-01-01 | Drug delivery systems in Krabbe disease—present and prospective approaches | Prabitha Priyadharshini, A; Umamaheswari, A; Vijayalakshmi, M; Chellappan, DK; Dua, K; Prabu, SL |
